We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $7.88B
1-Year Est. Return 6.82%
This Fund
S&P 500
This Quarter Est. Return
+5.49%
1 Year Est. Return
+6.82%
3 Year Est. Return
+32.7%
5 Year Est. Return
+41.26%
10 Year Est. Return
+331.36%
AUM
$8.18B
AUM Growth
+$575M
Cap. Flow
+$287M
Cap. Flow %
3.5%
Top 10 Hldgs %
22.5%
Holding
126
New
11
Increased
85
Reduced
21
Closed
9

Sector Composition

Rank Sector Weight
1 Healthcare 22.09%
2 Technology 17.08%
3 Industrials 16.69%
4 Financials 14.61%
5 Consumer Staples 13.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IART icon
1
Integra LifeSciences
IART
$1.37B
$242M 2.96%
4,447,689
+8,929
+0.2% +$426K
THS
2
DELISTED
Treehouse Foods
THS
$228M 2.78%
2,788,805
+170,155
+6% +$13.9M
BLKB icon
3
Blackbaud
BLKB
$1.99B
$192M 2.35%
2,239,678
-19,277
-0.9% -$1.58M
LNCE
4
DELISTED
Snyders-Lance, Inc.
LNCE
$189M 2.31%
5,459,708
+1,264,238
+30% +$46M
AWH
5
DELISTED
Allied World Assurance Co Hld Lt
AWH
$188M 2.3%
3,552,651
-311,835
-8% -$16.4M
WEX icon
6
WEX
WEX
$6.48B
$183M 2.24%
1,759,626
+65,791
+4% +$6.77M
WLY icon
7
John Wiley & Sons Class A
WLY
$2.85B
$172M 2.11%
3,267,113
+112,748
+4% +$5.9M
NUVA
8
DELISTED
NuVasive, Inc.
NUVA
$169M 2.06%
2,193,885
+285,605
+15% +$21.3M
GWRE icon
9
Guidewire Software
GWRE
$13.9B
$147M 1.79%
2,133,782
-23,098
-1% -$1.47M
RBA icon
10
RB Global
RBA
$21.7B
$131M 1.59%
4,540,719
+1,672,564
+58% +$51.9M
MDSO
11
DELISTED
Medidata Solutions, Inc.
MDSO
$127M 1.55%
1,619,637
-33,593
-2% -$2.34M
ATR icon
12
AptarGroup
ATR
$8.64B
$126M 1.55%
1,456,245
+276,865
+23% +$22.8M
NTRS icon
13
Northern Trust
NTRS
$22B
$118M 1.44%
1,211,255
+23,170
+2% +$2.08M
LH icon
14
Labcorp
LH
$25.5B
$113M 1.38%
850,273
+24,980
+3% +$3.06M
WWW icon
15
Wolverine World Wide
WWW
$1.67B
$112M 1.36%
3,982,523
+65,158
+2% +$1.65M
LOGM
16
DELISTED
LogMein, Inc.
LOGM
$109M 1.33%
1,044,144
+235,849
+29% +$25.8M
WFM
17
DELISTED
Whole Foods Market Inc
WFM
$107M 1.3%
2,532,430
-139,525
-5% -$5.08M
PB icon
18
Prosperity Bancshares
PB
$8.94B
$106M 1.29%
1,647,953
+35,273
+2% +$2.32M
RHT
19
DELISTED
Red Hat Inc
RHT
$106M 1.29%
1,102,670
-121,500
-10% -$10.8M
COO icon
20
Cooper Companies
COO
$14.2B
$105M 1.29%
1,758,720
-338,780
-16% -$18.4M
ALGN icon
21
Align Technology
ALGN
$12.9B
$104M 1.27%
694,340
-2,290
-0.3% -$311K
XRAY icon
22
Dentsply Sirona
XRAY
$2.82B
$103M 1.26%
1,594,785
+53,370
+3% +$3.37M
STE icon
23
Steris
STE
$22.9B
$103M 1.26%
1,266,010
+30,410
+2% +$2.31M
PANW icon
24
Palo Alto Networks
PANW
$257B
$97.1M 1.19%
4,353,750
+385,590
+10% +$7.79M
FLO icon
25
Flowers Foods
FLO
$1.58B
$96.1M 1.17%
5,549,975
+108,805
+2% +$2.05M

Similar funds

Champlain Investment Partners's Q2 2017 Portfolio in Review

As of Q2 2017, Champlain Investment Partners held 126 positions worth $8.18B, up 7.6% from $7.61B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Champlain Investment Partners deployed $287M of net new capital in Q2 2017, opening 11 new positions and adding to 85 existing holdings. Its largest new stake was CATALENT, INC.: 1,558,010 shares worth $54.7M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Dover, an estimated $21.2M trimmed.

  • Champlain Investment Partners's largest Q2 2017 buy was CATALENT, INC.: 1,558,010 shares worth $54.7M.
  • Champlain Investment Partners added most to RB Global in Q2 2017, an estimated $51.9M increase.
  • Champlain Investment Partners's biggest Q2 2017 reduction was Dover, cutting an estimated $21.2M.
  • Champlain Investment Partners fully exited AdvancePierre Foods Holdings in Q2 2017, selling an estimated $72.7M.
  • Champlain Investment Partners's ten largest holdings make up 22% of its $8.18B portfolio in Q2 2017.
  • Champlain Investment Partners opened 11 new positions and closed 9 in Q2 2017.
  • Champlain Investment Partners's portfolio value rose 7.6% quarter-over-quarter to $8.18B.

Based on Champlain Investment Partners's 13F filing for Q2 2017, filed 11 Aug 2017.